Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach

J Perinat Med. 2004;32(5):407-12. doi: 10.1515/JPM.2004.137.

Abstract

Aims: Risk estimation for Down's syndrome in antenatal serum screening with maternal age and multiple serum biomarkers is usually complicated and computationally intensive. We have developed a simple scoring system using the Spiegelhalter-Knill-Jones approach, which was based on Bayesian theorem and the logistic regression model.

Methods: A prospective data set with 3842 singleton pregnancies including 6 affected pregnancies served as "trained data". Maternal age, maternal serum alpha-fetoprotein and human chorionic gonadotrophin levels of each pregnant woman were adopted as the predictors to establish the scoring model using the S-KJ approach. Model validation was undertaken using a receiver operating characteristics (ROC) curve with another 3050 singleton pregnancies including 4 affected pregnancies ("validated data").

Results: For the trained data the sensitivity and specificity of the scoring system at cut-off value of 1:250 was 66.7% and 92.6%, respectively. For the validated data the sensitivity and specificity at the same cut-off point was 75% and 92.2%, respectively. The area under the ROC curve of the trained and validated data was 76.96% (95% CI: 51.80-100%), and 94.07% (95% CI: 84.47-100%), respectively.

Conclusions: The S-KJ scoring system has been demonstrated to be a simple, and efficient method for the risk estimation of Down's syndrome. This system can be applied to other antenatal serum screening systems.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Biomarkers / blood
  • Chorionic Gonadotropin / blood
  • Down Syndrome / blood*
  • Down Syndrome / epidemiology
  • Female
  • Humans
  • Logistic Models
  • Maternal Age
  • Predictive Value of Tests
  • Pregnancy
  • Pregnancy Trimester, Second
  • Prenatal Diagnosis / methods*
  • Prospective Studies
  • ROC Curve
  • Sensitivity and Specificity
  • Taiwan / epidemiology
  • alpha-Fetoproteins / metabolism

Substances

  • Biomarkers
  • Chorionic Gonadotropin
  • alpha-Fetoproteins